In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles Y Zhong, Z Ma, F Wang, X Wang, Y Yang, Y Liu, X Zhao, J Li, H Du, ... Nature biotechnology 37 (11), 1322-1331, 2019 | 432 | 2019 |
Tuning T cell receptor sensitivity through catch bond engineering X Zhao, EM Kolawole, W Chan, Y Feng, X Yang, MH Gee, KM Jude, ... Science 376 (6589), eabl5282, 2022 | 66 | 2022 |
Autoimmunity-associated T cell receptors recognize HLA-B* 27-bound peptides X Yang, LI Garner, IV Zvyagin, MA Paley, EA Komech, KM Jude, X Zhao, ... Nature 612 (7941), 771-777, 2022 | 55 | 2022 |
Lck bound to coreceptor is less active than free Lck Q Wei, J Brzostek, S Sankaran, J Casas, LSQ Hew, J Yap, X Zhao, ... Proceedings of the National Academy of Sciences 117 (27), 15809-15817, 2020 | 46 | 2020 |
T cell receptor and cytokine signal integration in CD8+ T cells is mediated by the protein Themis J Brzostek, N Gautam, X Zhao, EW Chen, M Mehta, DWH Tung, YL Chua, ... Nature immunology 21 (2), 186-198, 2020 | 46 | 2020 |
Facile discovery of surrogate cytokine agonists M Yen, J Ren, Q Liu, CR Glassman, TP Sheahan, LK Picton, FR Moreira, ... Cell 185 (8), 1414-1430. e19, 2022 | 38 | 2022 |
Nonstimulatory peptide–MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling X Zhao, S Sankaran, J Yap, CT Too, ZZ Ho, G Dolton, M Legut, EC Ren, ... Nature Communications 9 (1), 2716, 2018 | 19 | 2018 |
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy X Yang, D Nishimiya, S Löchte, KM Jude, M Borowska, CS Savvides, ... Nature Biotechnology 41 (7), 932-943, 2023 | 17 | 2023 |
A bead-based method for high-throughput mapping of the sequence-and force-dependence of T cell activation Y Feng, X Zhao, AK White, KC Garcia, PM Fordyce Nature Methods 19 (10), 1295-1305, 2022 | 16 | 2022 |
Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses F Ren, F Wang, A Baghdasaryan, Y Li, H Liu, RS Hsu, C Wang, J Li, ... Nature Biomedical Engineering, 1-14, 2023 | 9 | 2023 |
Use of single chain MHC technology to investigate co-agonism in human CD8+ T cell activation X Zhao, M Hamidinia, JAL Choo, CT Too, ZZ Ho, EC Ren, A Bertoletti, ... Journal of Visualized Experiments, 2019 | 6 | 2019 |
TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways W Chan, YM Cao, X Zhao, EC Schrom, D Jia, J Song, LV Sibener, S Dong, ... Journal of Experimental Medicine 220 (12), e20231242, 2023 | 5 | 2023 |
Time required for commitment to T cell proliferation depends on TCR affinity and cytokine response L Wu, R Balyan, J Brzostek, X Zhao, NRJ Gascoigne EMBO reports 24 (1), e54969, 2023 | 4 | 2023 |
The recent advancement of TCR-T cell therapies for cancer treatment: TCR-T cell therapies for cancer treatment X Zhao, S Shao, L Hu Acta Biochimica et Biophysica Sinica 56 (5), 663, 2024 | 1 | 2024 |
Non-stimulatory pMHC enhance CD8 T cell effector functions by recruiting coreceptor-bound Lck X Zhao, ENY Ng, KWS Leow, Q Wei, N Gascoigne, J Brzostek Frontiers in Immunology, 4138, 2021 | 1 | 2021 |